首页> 美国卫生研究院文献>other >FAT10 IS AN EPIGENETIC MARKER FOR LIVER PRENEOPLASIA IN A DRUG-PRIMED MOUSE MODEL OF TUMORIGENESIS
【2h】

FAT10 IS AN EPIGENETIC MARKER FOR LIVER PRENEOPLASIA IN A DRUG-PRIMED MOUSE MODEL OF TUMORIGENESIS

机译:FAT10是在以肺造血为主要成分的小鼠模型中肝癌前病变的标志物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

There is clinical evidence that chronic liver diseases in which MDBs (Mallory Denk Bodies) form progress to hepatocellular carcinoma. The present study provides evidence that links MDB formation induced by chronic drug injury, with preneoplasia and later to the formation of tumors, which develop long after drug withdrawal. Evidence indicated that this link was due to an epigenetic cellular memory induced by chronic drug ingestion. Microarray analysis showed that the expressions of many markers of preneoplasia (UBD, Alpha Fetoprotein, KLF6 and Glutathione-S-Transferase mu2) were increased together when the drug DDC was refed. These changes were suppressed by S-adenosylmethionine feeding, indicating that the drug was affecting DNA and histones methylation in an epigenetic manner. The link between MDB formation and neoplasia formation was likely due to the over expression of UBD (also called FAT10), which is up regulated in 90% of human hepatocellular carcinomas. Immunohistochemical staining of drug primed mouse livers showed that FAT10 positive liver cells persisted up to 4 months after drug withdrawal and they were still found in the livers of mice, 14 months after drug withdrawal. The refeeding of DDC increased the percent of FAT10 hepatocytes.
机译:有临床证据表明,其中MDB(马洛里登克尸体)形成的慢性肝病会进展为肝细胞癌。本研究提供了证据,证明由慢性药物损伤引起的MDB的形成与肿瘤形成前和后来与停药后很长时间发展的肿瘤的形成有关。有证据表明,这种联系是由于慢性药物摄入引起的表观遗传细胞记忆。芯片分析表明,当参考药物DDC时,许多前肾病标记(UBD,甲胎蛋白,KLF6和谷胱甘肽-S-转移酶mu2)的表达均增加。 S-腺苷甲硫氨酸的添加抑制了这些变化,表明该药物以表观遗传的方式影响DNA和组蛋白的甲基化。 MDB形成与瘤形成之间的联系可能是由于UBD(也称为FAT10)的过度表达所致,该表达在90%的人类肝细胞癌中被上调。药物致敏小鼠肝脏的免疫组织化学染色显示,停药后4个月FAT10阳性肝细胞持续存在,停药后14个月仍在小鼠肝脏中发现。 DDC的补料增加了FAT10肝细胞的百分比。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号